论文部分内容阅读
RNS系统RNS系统由一家名为NeuroPace的美国公司出品,于2013年11月14日获得FDA批准。该产品应用于可致残性局部癫痫频发、药物治疗无效的患者,有助于降低电线发病频率。其产品构成为一个可植入头皮下方颅骨中的信号生成器与可植入大脑中的电极。RNS系统具有感知脑电活动的能力,并能将其记录下来进行分析,从而对引起癫痫发作的可疑部位施以电刺激。该系统旨在癫痫尚未发作之时干扰患者的脑活动,可与药
RNS ™ System The RNS system, produced by a U.S. company called NeuroPace, received FDA approval on November 14, 2013. The product is used in patients with disabling local epilepsy and ineffective drug treatment to help reduce the frequency of electrical wiring. The product consists of a signal generator implantable in the skull below the scalp and an implantable electrode in the brain. The RNS system has the ability to sense EEG activity and record it for analysis to provide electrical stimulation of suspicious sites that cause seizures. The system is designed to interfere with patients’ brain activity when epilepsy has not yet occurred and can be used with medicine